Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Why Does the Influenza Tests Market Matter?
Influenza tests play an important role in diagnosing influenza infections and supporting clinical decision-making. The market is shaped by evolving testing needs, product technologies, competitive dynamics, healthcare systems, reimbursement policies, and medtech regulations.
This report provides a comprehensive view of the global Influenza Tests market across 39 countries, combining quantitative market data with qualitative analyst insights. It covers market revenue, units, product usage, average selling prices, company share and rankings, as well as country-specific regulatory and reimbursement environments through 2036.
The analysis helps medtech companies, investors, procurement teams, and strategy leaders understand market opportunities, competitive positioning, and long-term growth trends.

Key Insights in the Influenza Tests Market
The report provides insight into:
- Global Influenza Tests market size and revenue by segment
- Historical market data from 2015 and forecasts through 2036
- Units, product usage, average selling prices, and market values
- Global, regional, and country-level market trends
- Competitive dynamics and market trends
- Company market share and rankings where available
- Key industry trends shaping the market
- SWOT analysis of the Influenza Tests market
- Country-specific healthcare system insights
- Reimbursement policies across covered markets
- Medtech regulatory landscapes
- Key companies and competitive positioning
- Quantitative and qualitative market trends
Scope
What Will You Learn from This Influenza Tests Market Report?
This report provides insight into:
- How the Influenza Tests market has evolved since 2015
- Market revenue by segment and future market outlook through 2036
- Device volumes, product usage, pricing, and market values
- Regional and country-level market performance
- Competitive dynamics shaping the market
- Market share and rankings of leading companies
- Healthcare systems across individual countries
- Country-specific reimbursement policies
- Medtech regulatory environments
- Key industry trends and market drivers
- Opportunities for strategic investment and market expansion
- Companies and product portfolios shaping the competitive landscape
Who Should Buy This Influenza Tests Market Report?
This report may be valuable for:
- Chief marketing officers and medtech executives
- Medical device manufacturers
- Diagnostics companies
- Sourcing and procurement executives
- Sales and marketing teams
- Strategy and business development teams
- Market intelligence professionals
- Private equity investors
- Healthcare consultants
- Investment and corporate strategy teams
How Companies Use This Influenza Tests Market Analysis
Companies can use the report to evaluate market opportunities, competitive positioning, and country-level market conditions.
For example:
- Medtech companies can track market size, sales, volumes, pricing, and competitive trends.
- Diagnostics companies can assess market segments and evolving competitive dynamics.
- CMO executives can use market forecasts and competitive insights to support strategic planning and investment decisions.
- Procurement teams can evaluate the supply base and market conditions to support supplier selection and management.
- Sales and marketing teams can benchmark company share and identify attractive market segments.
- Business development teams can identify opportunities for strategic partnerships and market expansion.
- Private equity investors can assess market dynamics and identify potential investment targets.
- Market intelligence teams can monitor regional and country-level developments through 2036.
- Regulatory and market access teams can assess country-specific reimbursement and medtech regulatory environments.
Reasons to Buy
Benchmark the Influenza Tests Market Across Global and Country-Level Markets
The report enables users to benchmark the Influenza Tests market across 39 countries, including the US, UK, Germany, France, Italy, Spain, Brazil, China, India, Japan, Australia, Canada, South Korea, Saudi Arabia, the UAE, and other key markets.
Benchmarking includes:
- Market revenue
- Market volumes
- Product usage
- Average selling prices
- Market values
- Company share and rankings
- Regional market trends
- Competitive dynamics
- Healthcare systems
- Reimbursement policies
- Medtech regulatory environments
This provides a structured view of differences in market performance and market access across countries and regions.
Built on GlobalData Medtech Intelligence
GlobalData’s Influenza Tests market model combines quantitative and qualitative analysis with extensive market research methodologies.
The model integrates demand- and supply-side primary sources, including Key Opinion Leaders, alongside real-world data from government procedure databases, hospital purchasing databases, and proprietary online databases.
Each of the 39 country models is fully sourced and supported by epidemiology-based indications, while analyst commentary provides context around the quantitative market data.
Act Now to Identify Opportunities in the Influenza Tests Market
The Influenza Tests market continues to evolve across products, technologies, competitive players, and healthcare systems.
Use GlobalData’s Influenza Tests Market Analysis to track market performance from 2015 through 2036, benchmark companies and countries, assess regulatory and reimbursement environments, and identify opportunities for investment, partnerships, sales growth, and strategic expansion.
Cepheid Inc
Quidel Corp
bioMerieux SA
Sekisui Diagnostics LLC
DiaSorin SpA
Roche Diagnostics International Ltd
Becton Dickinson and Co
Qiagen NV
Thermo Fisher Scientific Inc
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more In Vitro Diagnostics reports

